Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 10,876

Sort by:

Anthrax Protective Antigen (pa) - Drugs in Development, 2021

US$ 3,000.00

Anthrax Protective Antigen (pa) - Drugs in Development, 2021 SUMMARY Anthrax Protective Antigen (pa) - Drugs in Development, 2021 provides in depth analysis on Anthrax Protective Antigen (pa) targeted...

April 2021 35 pages

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) (Immunology) - Drugs in Development, 2021 SUMMARY Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculit...

April 2021 30 pages

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the An...

April 2021 30 pages

Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021

US$ 3,000.00

Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 SUMMARY Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 provides in depth analysis on Antithrombin III (ATIII or SER...

April 2021 35 pages

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Anxiety Disorders pi...

April 2021 140 pages

Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Aortic Valve Stenosis pipeli...

April 2021 35 pages

Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021 SUMMARY Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein A (APOA or LPA) targeted pi...

April 2021 30 pages

Apolipoprotein A I (APOA1) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein A I (APOA1) - Drugs in Development, 2021 SUMMARY Apolipoprotein A I (APOA1) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein A I (APOA1) targeted pipeline thera...

April 2021 35 pages

Apolipoprotein C III (APOC3) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein C III (APOC3) - Drugs in Development, 2021 SUMMARY Apolipoprotein C III (APOC3) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein C III (APOC3) targeted pipeline...

April 2021 35 pages

Apolipoprotein E (APOE) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein E (APOE) - Drugs in Development, 2021 SUMMARY Apolipoprotein E (APOE) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein E (APOE) targeted pipeline therapeutics....

April 2021 45 pages

Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021 SUMMARY Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021 provides in depth analysis on Apolipoprote...

April 2021 30 pages

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - Drugs in Development, 2021

US$ 3,000.00

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - Drugs in Development, 2021 SUMMARY Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - D...

April 2021 35 pages

Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021

US$ 3,000.00

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021 SUMMARY Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021 pr...

April 2021 30 pages

Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) - Drugs in Development, 2021

US$ 3,000.00

Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) - Drugs in Development...

April 2021 30 pages

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) - Drugs in Development, 2021

US$ 3,000.00

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) - Drugs in Development, 2021 SUMMARY Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Syn...

April 2021 40 pages

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) - Drugs in Development, 2021

US$ 3,000.00

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) - Drugs in Development, 2021 SUMMARY Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein o...

April 2021 30 pages

Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Arenaviridae Inf...

April 2021 30 pages

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Development, 2021

US$ 3,000.00

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Development, 2021 SUMMARY Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Deve...

April 2021 30 pages

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021

US$ 3,000.00

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021 SUMMARY Aromatase (Estrogen Synthase or Cytochrome P 450AROM or C...

April 2021 35 pages

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) - Drugs in Development, 2021

US$ 3,000.00

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) - Drugs in Development, 2021 SUMMARY Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC...

April 2021 50 pages

Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Arteriosclerosis pipeline landscape. T...

April 2021 35 pages

Arthritis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Arthritis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Arthritis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Arthritis pipeline landscape. The report provides...

April 2021 105 pages

Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Articular Cartil...

April 2021 35 pages

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021

US$ 3,000.00

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021 SUMMARY Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2...

April 2021 35 pages

Ascites (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Ascites (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Ascites (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Ascites pipeline landscape. The report provides comp...

April 2021 30 pages

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021

US$ 3,000.00

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021 SUMMARY Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021 provides...

April 2021 35 pages

Astrocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Astrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Astrocytoma (Oncology) - Drugs in Development, 2021 provides an overview of the Astrocytoma pipeline landscape. The report provides comprehe...

April 2021 55 pages

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021

US$ 3,000.00

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021 SUMMARY Ataxin 3 (Machado Joseph Disease Protein 1 or...

April 2021 35 pages

Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Atopic Keratoconju...

April 2021 30 pages

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) - Drugs in Development, 2021

US$ 3,000.00

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) - Drugs in Development, 2021 SUMMARY ATP Dependent Clp Protease Proteolytic Subunit Mitochondri...

April 2021 30 pages

Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021

US$ 2,000.00

Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) (Women's Health) - Drugs in Development, 2021 SUMMARY Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital A...

April 2021 35 pages

Auto Inflammatory Disease (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Auto Inflammatory Disease (Immunology) - Drugs in Development, 2021 SUMMARY Auto Inflammatory Disease (Immunology) - Drugs in Development, 2021 provides an overview of the Auto Inflammatory Disease pi...

April 2021 35 pages

Autoimmune Hepatitis (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Autoimmune Hepatitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Autoimmune Hepatitis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Autoimmune Hepatitis pipel...

April 2021 40 pages

Avian Influenza (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Avian Influenza (Infectious Disease) - Drugs in Development, 2021 SUMMARY Avian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landsca...

April 2021 35 pages

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncology) - Drugs in Development, 2021 SUMMARY B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) (Oncol...

April 2021 220 pages

B-Cell Leukemia (Oncology) - Drugs in Development, 2021

US$ 2,000.00

B-Cell Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY B-Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the B-Cell Leukemia pipeline landscape. The report provi...

April 2021 100 pages

B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021

US$ 3,000.00

B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021 SUMMARY B Cell Lymphoma 2 (Bcl 2) - Drugs in Development, 2021 provides in depth analysis on B Cell Lymphoma 2 (Bcl 2) targeted pipeline therapeu...

April 2021 50 pages

B Cell Lymphoma/Leukemia 11A (B Cell CLL/Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) - Drugs in Development, 2021

US$ 3,000.00

B Cell Lymphoma/Leukemia 11A (B Cell CLL/Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) - Drugs in Developmen...

April 2021 30 pages

B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the B-Cell Non-Hodgkin Lymphoma...

April 2021 220 pages

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) - Drugs in Development, 2021

US$ 3,000.00

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) - Drugs in Development, 2021 SUMMARY B Lymphocyte Antigen CD19 (B L...

April 2021 35 pages

B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Drugs in Development, 2021

US$ 3,000.00

B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Drugs in Development, 2021 SUMMARY B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Drugs in Development, 2021 provides in depth analysis on B1 Brady...

April 2021 30 pages

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) - Drugs in Development, 2021

US$ 3,000.00

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) - Drugs in Development, 2021 SUMMARY B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) - Drugs in Development, 2021 provides in depth analysis on B2 Brady...

April 2021 30 pages

Bacillary Dysentery (Shigellosis) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Bacillary Dysentery (Shigellosis) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacillary Dysentery (Shigellosis) (Infectious Disease) - Drugs in Development, 2021 provides an overview of...

April 2021 55 pages

Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacillus Anthracis Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Baci...

April 2021 30 pages

Back Pain (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Back Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Back Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Back Pain pipeline landscape. The re...

April 2021 30 pages

Bacteremia (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Bacteremia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacteremia (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Bacteremia pipeline landscape. The report...

April 2021 45 pages

Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Bacterial Keratitis pipeline lands...

April 2021 30 pages

Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Bacterial Pneumonia pipe...

April 2021 40 pages

Bacterial Sepsis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Bacterial Sepsis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Bacterial Sepsis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Bacterial Sepsis pipeline land...

April 2021 40 pages

Filters

Clear all